208 related articles for article (PubMed ID: 37160814)
21. Metaplastic Carcinoma of the Breast: Case Series of a Single Institute and Review of the Literature.
Papatheodoridi A; Papamattheou E; Marinopoulos S; Ntanasis-Stathopoulos I; Dimitrakakis C; Giannos A; Kaparelou M; Liontos M; Dimopoulos MA; Zagouri F
Med Sci (Basel); 2023 May; 11(2):. PubMed ID: 37218987
[TBL] [Abstract][Full Text] [Related]
22. Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer.
Jung SY; Kim HY; Nam BH; Min SY; Lee SJ; Park C; Kwon Y; Kim EA; Ko KL; Shin KH; Lee KS; Park IH; Lee S; Kim SW; Kang HS; Ro J
Breast Cancer Res Treat; 2010 Apr; 120(3):627-37. PubMed ID: 20143153
[TBL] [Abstract][Full Text] [Related]
23. Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes.
Goh CW; Wu J; Ding S; Lin C; Chen X; Huang O; Chen W; Li Y; Shen K; Zhu L
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1877-1886. PubMed ID: 31089799
[TBL] [Abstract][Full Text] [Related]
24. Metaplastic breast cancer: an all-round multidisciplinary consensus.
Corso G; Criscitiello C; Nicosia L; Pesapane F; Vicini E; Magnoni F; Sibilio A; Zanzottera C; De Scalzi AM; Mannucci S; Marabelli M; Calvello M; Feroce I; Zagami P; Porta FM; Toesca A; Tarantino P; Nicolò E; Mazzarol G; La Vecchia C; Bonanni B; Leonardi MC; Veronesi P; Fusco N
Eur J Cancer Prev; 2023 Jul; 32(4):348-363. PubMed ID: 37021548
[TBL] [Abstract][Full Text] [Related]
25. Metaplastic carcinoma of the breast: Prognosis and response to systemic treatment in metastatic disease.
Takala S; Heikkilä P; Nevanlinna H; Blomqvist C; Mattson J
Breast J; 2019 May; 25(3):418-424. PubMed ID: 30925636
[TBL] [Abstract][Full Text] [Related]
26. Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic Subtype.
Tadros AB; Sevilimedu V; Giri DD; Zabor EC; Morrow M; Plitas G
Ann Surg Oncol; 2021 Aug; 28(8):4245-4253. PubMed ID: 33389291
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological characteristics and prognosis of breast cancer with special histological types: A surveillance, epidemiology, and end results database analysis.
Han Y; Wang J; Xu B
Breast; 2020 Dec; 54():114-120. PubMed ID: 32979771
[TBL] [Abstract][Full Text] [Related]
28. Transcriptomic alterations underlying metaplasia into specific metaplastic components in metaplastic breast carcinoma.
Lien HC; Hsu CL; Lu YS; Chen TW; Chen IC; Li YC; Huang CS; Cheng AL; Lin CH
Breast Cancer Res; 2023 Jan; 25(1):11. PubMed ID: 36707876
[TBL] [Abstract][Full Text] [Related]
29. The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer.
Liao HY; Zhang WW; Sun JY; Li FY; He ZY; Wu SG
J Cancer; 2018; 9(2):296-303. PubMed ID: 29344276
[No Abstract] [Full Text] [Related]
30. Metaplastic Breast Carcinoma Revisited; Subtypes Determine Outcomes: Comprehensive Pathologic, Clinical, and Molecular Review.
Khoury T
Clin Lab Med; 2023 Jun; 43(2):221-243. PubMed ID: 37169444
[TBL] [Abstract][Full Text] [Related]
31. Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer.
Yam C; Abuhadra N; Sun R; Adrada BE; Ding QQ; White JB; Ravenberg EE; Clayborn AR; Valero V; Tripathy D; Damodaran S; Arun BK; Litton JK; Ueno NT; Murthy RK; Lim B; Baez L; Li X; Buzdar AU; Hortobagyi GN; Thompson AM; Mittendorf EA; Rauch GM; Candelaria RP; Huo L; Moulder SL; Chang JT
Clin Cancer Res; 2022 Jul; 28(13):2878-2889. PubMed ID: 35507014
[TBL] [Abstract][Full Text] [Related]
32. Translational Aspects in Metaplastic Breast Carcinoma.
Barrientos-Toro EN; Ding Q; Raso MG
Cancers (Basel); 2024 Apr; 16(7):. PubMed ID: 38611109
[TBL] [Abstract][Full Text] [Related]
33. TROP2, androgen receptor, and PD-L1 status in histological subtypes of high-grade metaplastic breast carcinomas.
Chartier S; Brochard C; Martinat C; Coussy F; Feron JG; Kirova Y; Cottu P; Marchiò C; Vincent-Salomon A
Histopathology; 2023 Apr; 82(5):664-671. PubMed ID: 36527253
[TBL] [Abstract][Full Text] [Related]
34. Clinico-pathological features and prognosis of invasive micropapillary carcinoma compared to invasive ductal carcinoma: a population-based study from China.
Shi WB; Yang LJ; Hu X; Zhou J; Zhang Q; Shao ZM
PLoS One; 2014; 9(6):e101390. PubMed ID: 24977705
[TBL] [Abstract][Full Text] [Related]
35. Metaplastic Carcinoma of the Breast Is More Aggressive Than Triple-negative Breast Cancer: A Study From a Single Institution and Review of Literature.
El Zein D; Hughes M; Kumar S; Peng X; Oyasiji T; Jabbour H; Khoury T
Clin Breast Cancer; 2017 Aug; 17(5):382-391. PubMed ID: 28529029
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological characteristics and prognosis of metaplastic breast cancer versus triple-negative invasive ductal carcinoma: a retrospective analysis.
Yang X; Tang T; Zhou T
World J Surg Oncol; 2023 Nov; 21(1):364. PubMed ID: 37996840
[TBL] [Abstract][Full Text] [Related]
37. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators.
Song Y; Liu X; Zhang G; Song H; Ren Y; He X; Wang Y; Zhang J; Zhang Y; Sun S; Liang X; Sun Q; Pang D
World J Surg Oncol; 2013 Jun; 11():129. PubMed ID: 23738706
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological features, treatment patterns, and prognosis of squamous cell carcinoma of the breast: an NCDB analysis.
Zhu L; Chen K
BMC Cancer; 2019 Jan; 19(1):26. PubMed ID: 30621628
[TBL] [Abstract][Full Text] [Related]
39. The prognostic significance of metaplastic carcinoma of the breast (MCB)--a case controlled comparison study with infiltrating ductal carcinoma.
Lai HW; Tseng LM; Chang TW; Kuo YL; Hsieh CM; Chen ST; Kuo SJ; Su CC; Chen DR
Breast; 2013 Oct; 22(5):968-73. PubMed ID: 23787124
[TBL] [Abstract][Full Text] [Related]
40. A comparative clinicopathological and survival analysis of synchronous bilateral breast cancers.
Bai Y; Lu J; Wu H; Wang J; Niu Y; Pang J; Wu S; Liu Y; Liang Z
Histol Histopathol; 2022 Aug; 37(8):791-802. PubMed ID: 35285011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
